(Q45760981)

English

Antimicrobial activity and interaction of pefloxacin and its principal metabolites. Collaborative Antimicrobial Susceptibility Testing Group

scientific article published in June 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/2504598

Antimicrobial activity and interaction of pefloxacin and its principal metabolites. Collaborative Antimicrobial Susceptibility Testing Group (English)

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/2504598

1 reference

based on heuristic

inferred from title

author name string

R N Jones

1

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/2504598

publication date

1 June 1989

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/2504598

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/2504598

8

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/2504598

6

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/2504598

551-556

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/2504598

https://scigraph.springernature.com/pub.10.1007/bf01967479

0 references

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

1 reference

https://api.crossref.org/works/10.1007%2FBF01967479

21 January 2018

In vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin).

1 reference

https://api.crossref.org/works/10.1007%2FBF01967479

21 January 2018

Difloxacin metabolism and pharmacokinetics in humans after single oral doses

1 reference

https://api.crossref.org/works/10.1007%2FBF01967479

21 January 2018

Pharmacokinetics of pefloxacin in normal and impaired renal function

1 reference

https://pubmed.ncbi.nlm.nih.gov/2504598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pefloxacin in the treatment of nosocomial lower respiratory tract infections in intensive care patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2504598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro antimicrobial activity of enoxacin and its metabolites

1 reference

https://pubmed.ncbi.nlm.nih.gov/2504598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of cephalosporin metabolism: a lesson to be learned for future chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2504598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bactericidal activity and killing rate of serum in volunteers receiving pefloxacin alone or in combination with ceftazidime, piperacillin or mezlocillin against Pseudomonas aeruginosa.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2504598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01967479

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/2504598

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/2504598

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45760981&oldid=2081357603"